Skip to main content
Fig. 4 | BMC Infectious Diseases

Fig. 4

From: Incidence and predictors of major adverse drug events among drug-resistant tuberculosis patients on second-line anti-tuberculosis treatment in Amhara regional state public hospitals; Ethiopia: a retrospective cohort study

Fig. 4

Kaplan Meier hazard curve and log-rank test by haemoglobin level (a), co-morbidity (b), and age (c) of DR-TB patients with major adverse drug event on second line anti-TB drugs in Amhara regional State Public Hospitals from September 2010 to December 2017

Back to article page

BMC Infectious Diseases

ISSN: 1471-2334

Contact us